Stocks
Roivant Sciences Ltd.ROIV
NASDAQHealthcareBiotechnology$28.06-1.72%
A biotechnology platform that creates and develops subsidiary companies focused on specific drug candidates and therapeutic areas, often referred to as "Vants." Its pipeline spans immunology, dermatology, and other specialty indications, with value driven by clinical trial progress and partnerships ...
Market Cap: $20.1B52W Range: $8.73 – $30.33
Congressional Interest in Roivant Sciences Ltd. (ROIV)
1 member of Congress has disclosed 4 trades in Roivant Sciences Ltd. (ROIV), a Healthcare company. The buy/sell breakdown shows 2 purchases versus 2 sales. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
4
Unique Politicians
1
Buys
2
Sells
2
Who in Congress Is Trading ROIV?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2025-10-31 | Lisa McClain | sell | $1K – $15K |
| 2025-10-30 | Lisa McClain | sell | $1K – $15K |